📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
520 announcements match the current filters (relevance ≥ 5).
Waaree Energies Clarifies U.S. Customs Ruling; No Blanket Evasion Finding on Solar Imports
Waaree Energies has clarified a U.S. Customs and Border Protection (CBP) determination regarding its solar module exports. The CBP confirmed that Waaree did not use Chinese-origin cells in its U.S. exports and declined a petitioner's request for a blanket evasion finding. While the ruling affects a narrow subset of historical entries, the company is pursuing legal remedies through administrative and judicial reviews. This is significant as exports constitute approximately 47% of Waaree's TTM revenue of ₹26,537 Cr.
Confidence: HIGH
What changedWaaree received a specific determination from U.S. Customs (CBP) that clears it of broad trade evasion allegations while identifying issues with a limited number of past shipments.
Why it mattersThe U.S. is Waaree's primary export market; a blanket ban would have severely impacted its 12 GW capacity utilization and long-term growth strategy in North America.
Export Revenue Share: 47%TTM Revenue: ₹26,537 CrCurrent Module Capacity: 12 GWInvestigation Case No.: 8163
📅 Short termThe clarification is likely to reduce uncertainty and negative sentiment surrounding recent media reports of U.S. customs issues.
📈 Long termSuccessfully navigating U.S. trade regulations is vital for Waaree's goal of becoming an integrated global player and maintaining its high ROCE of 43%.
⚠ Risk flags
- Legal and litigation risks in U.S. courts
- Potential for future changes in U.S. trade tariffs
- Concentration risk in the U.S. export market
Key Highlights
CBP confirmed Waaree did not export solar modules manufactured using Chinese-origin cells to the U.S.
CBP declined a request to apply an evasion finding to all of Waaree's imports, limiting it to a narrow historical subset.
Export revenue represents 47% of total revenue, making U.S. market access critical for the ₹91,696 Cr market cap company.
The company is evaluating legal remedies including judicial review before the U.S. Court of International Trade.
Current U.S. business operations and manufacturing deliveries continue without impact.
👀 What to Watch
Monitor the progress of the de novo administrative review and any potential judicial rulings regarding the historical import entries. Investors should also track U.S. trade policy changes which remain a key risk factor for the 47% export revenue stream.
Bajaj Healthcare First in India to Get SEC Nod for Cenobamate Tablets
Bajaj Healthcare (BHL) has become the first company in India to receive a recommendation from the Subject Expert Committee (SEC) of the CDSCO to manufacture and market Cenobamate Tablets. The recommendation covers six dosage strengths ranging from 12.5mg to 200mg for treating partial-onset seizures in adults. This next-generation antiseizure medication marks a significant entry into the specialty Central Nervous System (CNS) therapy market for the company. The move is expected to enhance BHL's product portfolio and market share in the epilepsy treatment segment.
Key Highlights
First-mover advantage in India for Cenobamate Tablets following SEC recommendation.
Recommended for 6 dosage strengths: 12.5mg, 25mg, 50mg, 100mg, 150mg, and 200mg.
Targets the high-growth Central Nervous System (CNS) specialty segment for adult epilepsy.
Clinical studies indicate significant seizure reduction and high seizure freedom rates for the drug.
👀 What to Watch
This is a positive regulatory milestone that gives BHL a competitive edge in the CNS segment; investors should monitor the timeline for final marketing approval and commercial launch.
Saregama India Reaffirmed CARE AA-; Stable and Assigned A1+ Rating for ₹233.50 Cr Facilities
CARE Ratings has reaffirmed Saregama India's long-term bank facility rating at 'CARE AA-; Stable' for a reduced amount of ₹100 crore. The agency also assigned a new 'CARE A1+' rating for a short-term line of credit worth ₹130 crore and reaffirmed the 'CARE A1+' rating for ₹3.50 crore in non-fund based limits. The total rated bank facilities now stand at ₹233.50 crore, based on the company's audited financial performance for FY26. These high-grade ratings indicate a very strong degree of safety regarding timely servicing of financial obligations.
Key Highlights
Long-term rating for ₹100 crore bank facilities reaffirmed at CARE AA- with a Stable outlook.
New short-term rating of CARE A1+ assigned to a ₹130 crore line of credit from ICICI Bank.
Existing short-term non-fund based limits of ₹3.50 crore reaffirmed at CARE A1+.
Total bank facilities under rating increased to ₹233.50 crore from the previous ₹105 crore level.
Ratings are based on the company's audited operational and financial performance for the fiscal year 2026.
👀 What to Watch
The reaffirmation and assignment of high credit ratings (AA- and A1+) reflect Saregama's strong balance sheet and low credit risk. Investors can remain confident in the company's financial stability and its ability to access low-cost capital for future growth.
Religare Housing Finance Appoints Pavan Kumar Gupta as MD & CEO
Religare Enterprises Limited (REL) has announced the appointment of Mr. Pavan Kumar Gupta as the Managing Director and CEO of its step-down subsidiary, Religare Housing Development Finance Corporation Limited (RHDFCL). Mr. Gupta brings over 30 years of experience in the housing finance and mortgage sector, having previously served as the CEO of Muthoot Housing Finance. The appointment is effective from July 01, 2026, with Mr. Gupta joining as MD & CEO designate on June 25, 2026. This leadership change is aimed at scaling and transforming the subsidiary's housing finance business.
Key Highlights
Mr. Pavan Kumar Gupta appointed as MD & CEO of RHDFCL effective July 01, 2026
Brings 30+ years of industry experience, including a former role as CEO of Muthoot Housing Finance
Spent 17 years in senior leadership roles at DHFL, Deutsche Postbank Home Finance, and BHW Birla Home Finance
Academic credentials include All India Rank 1 in CFA Level 3 and University Rank 2 in MBA
👀 What to Watch
Investors should monitor the performance of the housing finance subsidiary under new leadership as it contributes to the parent company's consolidated growth. No immediate action is required, but the hire of a seasoned industry veteran is a positive signal for the subsidiary's strategic direction.
Bajaj Healthcare Closes Trading Window for Business Unit Sale and Q1 FY27 Results
Bajaj Healthcare Limited has announced a trading window closure for designated persons starting June 23, 2026, in relation to the sale of an operational business unit. A second closure will commence on July 1, 2026, for the declaration of un-audited financial results for the quarter ending June 30, 2026. Both windows will remain closed until 48 hours after the respective events (signing of definitive agreements and results declaration). This is a mandatory compliance step under SEBI Insider Trading Regulations.
Key Highlights
Trading window closed from June 23, 2026, due to the sale of an operational business unit.
Closure for the business sale remains until 48 hours after the execution of definitive agreements.
Quarterly results trading window closure begins July 1, 2026, for the period ending June 30, 2026.
Restrictions apply to all Designated Persons and their immediate relatives per SEBI PIT Regulations.
The company previously disclosed the business unit sale on June 23, 2026, under Regulation 30.
👀 What to Watch
Investors should monitor for the formal execution of the business unit sale agreements as this could impact the company's asset base and valuation. No immediate action is required as this is a standard regulatory filing.
Saregama Appoints Abhishek Kapoor as CFO; Kuldeep Kothari Named Interim CFO
Saregama India Limited has announced a transition in its financial leadership, appointing Mr. Abhishek Kapoor as the new CFO effective July 15, 2026. Mr. Kapoor brings over 25 years of experience and currently serves as the CFO of Sula Vineyards Limited. To ensure continuity, Mr. Kuldeep Kothari, a 7-year veteran of the company with 23 years of total experience, has been appointed as Interim CFO from June 24, 2026, until July 14, 2026. This structured transition suggests a focus on maintaining stability in financial operations and governance.
Key Highlights
Mr. Abhishek Kapoor appointed as CFO and Key Managerial Personnel effective July 15, 2026.
Mr. Kuldeep Kothari appointed as Interim CFO from June 24, 2026, to July 14, 2026.
New CFO Abhishek Kapoor has 25+ years of experience across Media, FMCG, and Manufacturing sectors.
Interim CFO Kuldeep Kothari has 23+ years of experience, including 7 years within Saregama's finance function.
The Board meeting for these approvals lasted approximately 65 minutes on June 24, 2026.
👀 What to Watch
Investors should view this as a routine but important leadership update; the recruitment of a CFO from another listed entity (Sula Vineyards) is a positive indicator of talent acquisition. No immediate action is required, but watch for any changes in financial reporting or capital allocation strategies under the new leadership.
Saregama Appoints Abhishek Kapoor as CFO; Kuldeep Kothari Named Interim CFO
Saregama India Limited has announced the appointment of Abhishek Kapoor as its new Chief Financial Officer (CFO) effective July 15, 2026. Mr. Kapoor is a seasoned finance leader with over 25 years of experience and currently serves as the CFO of Sula Vineyards. To ensure a smooth transition, Kuldeep Kothari, who has 23 years of experience and has been with Saregama for 7 years, will serve as Interim CFO from June 24 to July 14, 2026. This leadership change brings in a professional with significant experience in the Media, Entertainment, and FMCG sectors.
Key Highlights
Abhishek Kapoor appointed as CFO and Key Managerial Personnel effective July 15, 2026.
Kuldeep Kothari appointed as Interim CFO from June 24, 2026, to July 14, 2026.
New CFO Abhishek Kapoor brings 25+ years of experience, joining from listed entity Sula Vineyards.
Interim CFO Kuldeep Kothari has been with the company for 7 years and has 23+ years of total finance experience.
👀 What to Watch
Investors should monitor the transition and look for any shifts in financial strategy or capital allocation once the new CFO takes charge in July. No immediate action is required as this appears to be a planned and orderly management transition.
Saregama Appoints Abhishek Kapoor as CFO; Kuldeep Kothari Named Interim CFO
Saregama India Limited has announced the appointment of Abhishek Kapoor as its new Chief Financial Officer, effective July 15, 2026. Mr. Kapoor is a seasoned finance professional with over 25 years of experience and currently serves as the CFO of Sula Vineyards Limited. To bridge the transition period, the company has appointed Kuldeep Kothari as Interim CFO from June 24, 2026, until July 14, 2026. This leadership change appears well-planned to ensure continuity in the company's financial management and strategic oversight.
Key Highlights
Abhishek Kapoor appointed as CFO and Key Managerial Personnel effective July 15, 2026.
Mr. Kapoor brings 25+ years of experience from sectors including Media, Entertainment, and FMCG.
Kuldeep Kothari appointed as Interim CFO from June 24, 2026, to July 14, 2026, to ensure continuity.
The new CFO, Abhishek Kapoor, is currently the CFO of Sula Vineyards Limited and an IIM Kozhikode alumnus.
Interim CFO Kuldeep Kothari has been with Saregama for 7 years and has 23 years of total experience.
👀 What to Watch
Investors should monitor the transition but can take confidence in the appointment of a CFO with significant experience in listed consumer-driven companies. No immediate portfolio changes are recommended based on this administrative update.
Saregama Appoints Abhishek Kapoor as CFO; Kuldeep Kothari Named Interim CFO
Saregama India Limited has announced a transition in its financial leadership, appointing Mr. Abhishek Kapoor as the new Chief Financial Officer effective July 15, 2026. Mr. Kapoor joins from Sula Vineyards, bringing over 25 years of experience in finance and strategy across various consumer-driven sectors. To bridge the gap until his arrival, the company has appointed Mr. Kuldeep Kothari, a 7-year veteran of the firm with 23 years of total experience, as the Interim CFO starting June 24, 2026. This move appears to be a planned succession to ensure continuity in the company's financial operations and regulatory compliance.
Key Highlights
Mr. Abhishek Kapoor appointed as permanent CFO and Key Managerial Personnel effective July 15, 2026
Mr. Kapoor brings 25+ years of experience and is the current CFO of Sula Vineyards Limited
Mr. Kuldeep Kothari appointed as Interim CFO from June 24, 2026, to July 14, 2026
Mr. Kothari has 23+ years of finance experience and has been with Saregama for 7 years
The appointments were approved in a Board meeting held on June 24, 2026, lasting approximately 65 minutes
👀 What to Watch
Investors should monitor the transition for any changes in financial strategy or capital allocation policies under the new CFO. The appointment of an experienced leader from another listed entity is generally a positive sign for corporate governance.
Saregama Appoints Abhishek Kapoor as CFO; Kuldeep Kothari Named Interim CFO
Saregama India Limited has announced a strategic leadership transition with the appointment of Mr. Abhishek Kapoor as Chief Financial Officer, effective July 15, 2026. Mr. Kapoor is a seasoned finance professional with over 25 years of experience and currently serves as the CFO of Sula Vineyards Limited. To bridge the transition period, Mr. Kuldeep Kothari, a 7-year veteran of the company with 23 years of total experience, has been appointed as Interim CFO from June 24 to July 14, 2026. This move ensures continuity in the company's financial leadership and brings in expertise from a high-growth listed consumer entity.
Key Highlights
Mr. Abhishek Kapoor appointed as CFO and Key Managerial Personnel effective July 15, 2026
Mr. Kapoor brings 25+ years of experience from sectors including Media, FMCG, and Manufacturing
Mr. Kuldeep Kothari appointed as Interim CFO from June 24, 2026, to July 14, 2026, to ensure continuity
The new CFO, Abhishek Kapoor, is an IIM Kozhikode alumnus and current CFO of Sula Vineyards Limited
Board meeting for these approvals concluded in approximately 65 minutes on June 24, 2026
👀 What to Watch
Investors should view this as a positive step toward professionalizing management with a seasoned CFO from a listed peer. Monitor future earnings calls for any shifts in financial strategy or capital allocation under the new leadership.
Religare Finvest Receives RBI Approval for Srinivasan Karthik as Managing Director
Religare Enterprises Limited (REL) has announced that the Reserve Bank of India (RBI) has approved the appointment of Mr. Srinivasan Karthik as a director for its material subsidiary, Religare Finvest Limited (RFL). Mr. Karthik, who has been serving as the CEO of RFL since May 5, 2026, will now also take on the role of Managing Director effective June 23, 2026. This regulatory clearance follows an application filed on May 6, 2026, and is a key step in stabilizing the leadership at the subsidiary level. The appointment remains subject to final approval from the shareholders of RFL.
Key Highlights
RBI provided formal approval for the appointment of Mr. Srinivasan Karthik on June 23, 2026.
Mr. Karthik has been the CEO and Key Managerial Personnel of Religare Finvest since May 5, 2026.
The dual role of CEO and Managing Director becomes effective from June 23, 2026, pending shareholder approval.
Religare Finvest Limited is a material subsidiary of the listed entity Religare Enterprises Limited.
👀 What to Watch
Investors should monitor the leadership transition as a sign of regulatory progress for the subsidiary. No immediate action is required, but stability in management at RFL is a positive indicator for the parent company's governance.
Waaree Energies CPO Sanjeev Pushkarna Resigns Effective June 19, 2026
Waaree Energies Limited has announced the resignation of Mr. Sanjeev Pushkarna from his role as Chief Procurement Officer (CPO). The resignation was effective from the close of business hours on June 19, 2026. As a key Senior Management Personnel (SMP), his departure is a mandatory disclosure under SEBI Regulation 30. The company has not yet announced a replacement for this critical supply chain role.
Key Highlights
Mr. Sanjeev Pushkarna resigned from the position of Chief Procurement Officer.
The resignation took effect at the close of business hours on June 19, 2026.
Disclosure made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company is currently in the process of managing the transition for this Senior Management role.
👀 What to Watch
Investors should monitor the company's upcoming announcements regarding the appointment of a new CPO to ensure continuity in procurement and supply chain efficiency.
Share India Securities to Raise ₹50 Crore via NCDs at 10.50% Coupon
Share India Securities Limited has approved the issuance of 50,000 secured, rated, senior, listed Non-Convertible Debentures (NCDs) with a face value of ₹10,000 each, totaling ₹50 Crores. This issuance is part of a larger ₹300 Crore debt-raising plan previously authorized in July 2025. The NCDs offer a coupon rate of 10.50% per annum with monthly interest payments and a tenure of up to 15 months. The debt is secured by a 1.35x cover on current assets and receivables, along with personal guarantees from the promoters.
Key Highlights
Issuance of up to 50,000 NCDs aggregating to a total of ₹50 Crores on a private placement basis.
Coupon rate fixed at 10.50% per annum with a monthly interest payout schedule.
Short-term tenure of up to 15 months with a lump sum principal repayment at maturity.
Security includes a 1.35x asset cover on current assets and receivables plus promoter personal guarantees.
The NCDs are proposed to be listed on the Wholesale Debt Market (WDM) segment of the BSE.
👀 What to Watch
Investors should view this as a routine capital-raising activity to support the company's lending and margin trading business. Monitor the company's leverage ratios and the growth in its interest-earning assets following this infusion.
Waaree Renewable Technologies Completes 55% Acquisition of Associated Power Structures
Waaree Renewable Technologies Limited (WAAREERTL) has finalized the acquisition of a 55% controlling stake in Associated Power Structures Private Limited (APSPL). The transaction was executed through a combination of primary share allotments and secondary share transfers. Consequently, APSPL has now become a subsidiary of WAAREERTL, which is expected to enhance the company's operational capabilities in the power infrastructure sector.
Key Highlights
Acquired a 55% equity stake in Associated Power Structures Private Limited (APSPL).
APSPL has officially become a subsidiary of Waaree Renewable Technologies Limited.
The acquisition involved both primary allotment and secondary transfer of equity shares.
The completion follows a series of regulatory intimations starting from January 26, 2026.
👀 What to Watch
Investors should view this as a growth-oriented move and monitor the consolidated financial performance in future quarters to assess the synergy benefits from APSPL.
Waaree Renewable Receives ₹30.91 Cr Scope Enhancement; Total EPC Contract Reaches ₹1,044.69 Cr
Waaree Renewable Technologies Limited (WAAREERTL) has secured an enhancement in the scope of work for an existing EPC contract for a 980 MWp / 700 MWac Solar Power Plant. The commercial order value has been increased by ₹30.91 crore, taking the total aggregate contract value to ₹1,044.69 crore inclusive of taxes. The project is being executed for a leading domestic renewable energy company in India. This update follows the original letter of award initially disclosed in February 2024.
Key Highlights
Scope of work enhanced for a major 980 MWp / 700 MWac Solar Power Plant EPC project.
Incremental order value of ₹30.91 crore added to the existing commercial contract.
Total contract value now stands at ₹1,044.69 crore inclusive of taxes.
The contract is awarded by a leading domestic renewable energy entity.
Terms and conditions of the original contract remain unchanged, ensuring continuity in execution.
👀 What to Watch
Investors should take this as a positive indicator of the company's ability to scale existing projects and maintain strong relationships with Tier-1 renewable energy players. Monitor the execution progress of this ₹1,000+ crore project as it will be a significant revenue driver.
Waaree Energies Shareholders Approve ₹10,000 Crore QIP and New CEO Appointment
Waaree Energies Limited has received shareholder approval to raise up to ₹10,000 crores through a Qualified Institutions Placement (QIP). The resolution passed with an overwhelming 99.58% majority, signaling strong investor confidence in the company's growth plans. Additionally, shareholders ratified the appointment of Mr. Jignesh Devchandbhai Rathod as the Whole-Time Director and CEO. The voting process saw a high participation rate of 81.58% of the total outstanding shares.
Key Highlights
Approved a massive capital raise of up to ₹10,000 crores via QIP or other eligible securities.
Mr. Jignesh Devchandbhai Rathod appointed as Whole-Time Director and CEO with 99.1% votes in favor.
The QIP resolution received 99.58% support, including 96.58% from institutional investors.
Total voting turnout was 81.58%, representing 23.46 crore votes out of 28.76 crore shares.
The capital raise is intended to fund future growth and expansion in the renewable energy sector.
👀 What to Watch
Investors should watch for the specific timing and pricing of the QIP, as the ₹10,000 crore infusion indicates aggressive expansion but will result in equity dilution.
Waaree Renewable Extends Acquisition Completion Date to June 30, 2026
Waaree Renewable Technologies Limited has announced a short delay in the acquisition of Associated Power Structures Private Limited. The completion, which was previously scheduled for June 15, 2026, is now expected to be finalized by June 30, 2026. The company cited procedural requirements related to the transfer of existing securities and the allotment of fresh securities as the reason for the extension.
Key Highlights
Acquisition completion date for Associated Power Structures Private Limited extended from June 15 to June 30, 2026.
Delay is attributed to procedural requirements involving security transfers and fresh issuance of shares.
This update follows previous disclosures regarding the acquisition made on January 26 and May 07, 2026.
The transaction involves both the acquisition of existing securities and the fresh issuance of new securities.
👀 What to Watch
Investors should treat this as a routine procedural delay and monitor for the final completion announcement by the end of June 2026.
Waaree Energies Secures 800 MW Solar Module Supply Order for FY 2026-27
Waaree Energies Limited has received a significant domestic order for the supply of 800 MW of solar modules from a leading energy solutions provider. The contract is a one-time order scheduled for execution during the Financial Year 2026-27. This win enhances the company's revenue visibility for the upcoming fiscal year and reinforces its position in the domestic solar market. The transaction is not a related party transaction and involves no interest from the promoter group.
Key Highlights
Awarded a contract to supply 800 MW of solar modules.
Execution timeline is set for the Financial Year 2026-27.
Order received from a renowned domestic energy solutions provider.
The contract is a one-time supply agreement with no related party involvement.
👀 What to Watch
Investors should monitor the company's execution capabilities and the impact of this large-scale order on future quarterly margins.
Thyrocare Recommends Final Dividend of ₹7.00 Per Share for FY 2025-26
Thyrocare Technologies has recommended a final dividend of ₹7.00 per equity share for the financial year ended March 31, 2026. This is in addition to the interim dividend of ₹7.00 already paid, bringing the total dividend for FY 2025-26 to ₹14.00 per share. The company has set June 23, 2026, as the record date and June 30, 2026, as the AGM date for shareholder approval. Detailed tax deduction at source (TDS) guidelines have been issued, requiring documentation submission by June 26, 2026.
Key Highlights
Recommended final dividend of ₹7.00 per equity share (70% of face value).
Total dividend for FY 2025-26 reaches ₹14.00 per share including interim payout.
Record date for dividend eligibility is fixed as Tuesday, June 23, 2026.
Standard TDS rate of 10% applies for resident shareholders with valid PAN.
Deadline for submitting tax-related declarations and documents is June 26, 2026.
👀 What to Watch
Investors should ensure their PAN and bank account details are updated with their DP and submit Form 15G/15H or other tax exemption documents by June 26 to minimize TDS.
CARE Ratings FY26 PAT up 24% to ₹173.7 Cr; AGM Scheduled for July 3, 2026
CARE Ratings Limited has announced its 33rd Annual General Meeting for July 3, 2026, following a strong financial performance in FY 2025-26. The company reported an 18% growth in revenue to ₹473.07 crore and a 24% increase in PAT to ₹173.70 crore. Profitability remains robust with an EBITDA margin of 42% and a PAT margin of 33%. Additionally, the company has fixed June 26, 2026, as the record date for dividend payments.
Key Highlights
Revenue from operations increased 18% YoY to ₹473.07 crore for FY 2025-26.
Profit After Tax (PAT) grew by 24% to ₹173.70 crore with an EPS of ₹57.06.
Maintains a dominant 58% market share in the ESG ratings (Category 1, Issuer-pays) segment.
CareEdge Global expanded sovereign rating coverage to 45 countries, representing 85% of global GDP.
Dividend record date and e-voting cut-off set for June 26, 2026.
👀 What to Watch
Investors should ensure they hold shares by the June 26 record date to qualify for the dividend. The strong margin profile and successful global expansion into sovereign ratings suggest a positive long-term outlook for the stock.
